Literature DB >> 15464450

MLL: a histone methyltransferase disrupted in leukemia.

Jay L Hess1.   

Abstract

Rearrangements of the MLL gene, which is located at chromosome 11q23, are associated with aggressive acute leukemias in both children and adults. MLL regulates Hox gene expression through direct promoter binding and histone modification. MLL rearrangements occurring in leukemia include MLL fusion genes, partial tandem duplications of MLL and MLL amplification. MLL fusions and amplification upregulate Hox expression, apparently resulting in a block of hematopoietic differentiation. Future therapies for MLL-associated leukemia might involve blocking Hox gene upregulation by using fusion proteins or inhibiting the activity of Hox proteins themselves.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15464450     DOI: 10.1016/j.molmed.2004.08.005

Source DB:  PubMed          Journal:  Trends Mol Med        ISSN: 1471-4914            Impact factor:   11.951


  132 in total

Review 1.  Triggers for genomic rearrangements: insights into genomic, cellular and environmental influences.

Authors:  Ram-Shankar Mani; Arul M Chinnaiyan
Journal:  Nat Rev Genet       Date:  2010-11-03       Impact factor: 53.242

Review 2.  Regulatory non-coding RNAs: revolutionizing the RNA world.

Authors:  Biao Huang; Rongxin Zhang
Journal:  Mol Biol Rep       Date:  2014-02-19       Impact factor: 2.316

3.  Bisphenol-A induces expression of HOXC6, an estrogen-regulated homeobox-containing gene associated with breast cancer.

Authors:  Imran Hussain; Arunoday Bhan; Khairul I Ansari; Paromita Deb; Samara A M Bobzean; Linda I Perrotti; Subhrangsu S Mandal
Journal:  Biochim Biophys Acta       Date:  2015-02-25

4.  Menin-MLL inhibitors reverse oncogenic activity of MLL fusion proteins in leukemia.

Authors:  Jolanta Grembecka; Shihan He; Aibin Shi; Trupta Purohit; Andrew G Muntean; Roderick J Sorenson; Hollis D Showalter; Marcelo J Murai; Amalia M Belcher; Thomas Hartley; Jay L Hess; Tomasz Cierpicki
Journal:  Nat Chem Biol       Date:  2012-01-29       Impact factor: 15.040

5.  Interaction of MLL amino terminal sequences with menin is required for transformation.

Authors:  Corrado Caslini; Zhaohai Yang; Mohamad El-Osta; Thomas A Milne; Robert K Slany; Jay L Hess
Journal:  Cancer Res       Date:  2007-08-01       Impact factor: 12.701

Review 6.  Roles of a trithorax group gene, MLL, in hematopoiesis.

Authors:  Ryoichi Ono; Tetsuya Nosaka; Yasuhide Hayashi
Journal:  Int J Hematol       Date:  2005-05       Impact factor: 2.490

7.  Musashi2 sustains the mixed-lineage leukemia-driven stem cell regulatory program.

Authors:  Sun-Mi Park; Mithat Gönen; Ly Vu; Gerard Minuesa; Patrick Tivnan; Trevor S Barlowe; James Taggart; Yuheng Lu; Raquel P Deering; Nir Hacohen; Maria E Figueroa; Elisabeth Paietta; Hugo F Fernandez; Martin S Tallman; Ari Melnick; Ross Levine; Christina Leslie; Christopher J Lengner; Michael G Kharas
Journal:  J Clin Invest       Date:  2015-02-09       Impact factor: 14.808

Review 8.  Chromosomal rearrangements leading to MLL gene fusions: clinical and biological aspects.

Authors:  David P Harper; Peter D Aplan
Journal:  Cancer Res       Date:  2008-12-15       Impact factor: 12.701

9.  MLL5 contributes to hematopoietic stem cell fitness and homeostasis.

Authors:  Yan Zhang; Jasmine Wong; Mark Klinger; Mary T Tran; Kevin M Shannon; Nigel Killeen
Journal:  Blood       Date:  2008-09-25       Impact factor: 22.113

Review 10.  Regulating the leukaemia stem cell.

Authors:  Michael L Cleary
Journal:  Best Pract Res Clin Haematol       Date:  2009-12       Impact factor: 3.020

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.